MINI FUTURE LONG - MERCK & CO. | Real-time Euronext Paris 08:53:53 2024-05-22 EDT | ||
| 4.687 EUR | -0.38% |
|
| Current month | -1.18% | ||
| 1 month | +8.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 4.687 | -0.38% |
| 24-05-21 | 4.705 | -0.84% |
| 24-05-20 | 4.745 | +1.63% |
| 24-05-17 | 4.669 | -0.79% |
| 24-05-16 | 4.706 | +1.03% |
Real-time Euronext Paris
Last update May 22, 2024 at 08:53 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| K3MMB | |
| ISIN | NLBNPNL2IZK9 |
| Date issued | 2023-10-04 |
| Strike | 79.96 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.075 € |
|---|---|
| Lowest since issue | 2.005 € |
| Spread | 0.114 € |
| Spread % | 2.39% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.8
USD
Average target price
141.6
USD
Spread / Average Target
+8.32%
- Stock Market
- Certificates
- K3MMB Certificat
